Elsevier Science, Inc.

SHERPA: Unknown

People

  1. Offit
    Offit
  2. Robson
    Robson
  3. Stadler
    Stadler
  4. Kemel
    Kemel
  5. Mandelker
    Mandelker
  6. Walsh
    Walsh
  7. Birsoy
    Birsoy
  8. Carlo
    Carlo
  9. Abida
    Abida
  10. Autio
    Autio

Groups

  1. Breast Medicine Service (11)
  2. Clinical Genetics Service (11)
  3. Department of Medicine (11)
  4. Population Sciences Research Program (11)
  5. Solid Tumor Oncology Division (11)
  6. Survivorship Research (11)
  7. GSK Faculty (10)
  8. Center for Pancreatic Cancer Research (6)
  9. Human Oncology and Pathogenesis Program (6)
  10. General Oncology Service (4)
Search Within
  1. "Breast Medicine Service"
  2. "Clinical Genetics Service"
Formats
  1. Journal Article (6)
  2. Meeting Abstract (5)
Groups
  1. Breast Medicine Service (11)
  2. Clinical Genetics Service (11)
  3. Department of Medicine (11)
  4. Population Sciences Research Program (11)
  5. Solid Tumor Oncology Division (11)
  6. Survivorship Research (11)

More Groups

People
  1. Kenneth Offit (9)
  2. Mark Robson (9)
  3. Diana Mandelker (6)
  4. Zsofia Stadler (6)
  5. Ozge Birsoy (5)
  6. Liying Zhang (4)

More People

Years
  1. 2023 (2)
  2. 2020 (1)
  3. 2019 (2)
  4. 2017 (1)
  5. 2016 (1)
  6. 2009 (1)

More Years

Publications
  1. Journal of Molecular Diagnostics (5)
  2. Lancet (3)
  3. European Urology (1)
  4. Journal of Urology (1)
  5. Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis (1)

Results (11)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical impact of a rapid genetic testing model for advanced prostate cancer patients
    Journal Article

    Breen, K. E.; Symecko, H.; Spielman, K.; Gebert, R.; Shah, I. H.; Pundock, S.; Batson, M.; Narayan, V. K.; Stadler, Z. K.; Autio, K. A.; more...
    Journal of Urology (2023)

    Fulltext@MSK | Save
  • Gene-based confirmatory germline testing following tumor-only sequencing of prostate cancer
    Journal Article

    Truong, H.; Breen, K.; Nandakumar, S.; Sjoberg, D. D.; Kemel, Y.; Mehta, N.; Lenis, A. T.; Reisz, P. A.; Carruthers, J.; Benfante, N.; more...
    European Urology (2023)

    Fulltext@MSK | Save
  • Mosaicism in cancer susceptibility genes in unselected cancer patients
    Meeting Abstract

    Mandelker, D.; Pareja, F.; Ptashkin, R.; Selenica, P.; Jairam, S.; Vahdatinia, M.; Patel, J.; Da Silva, E.; Riaz, N.; Stadler, Z.; more...
    Journal of Molecular Diagnostics (2020)

    Fulltext@MSK | Save
  • Integrated germline and somatic analysis identifies actionable cancer predisposing germline mutations in 9,734 patients with advanced cancers
    Meeting Abstract

    Jayakumaran, G.; Mandelker, D.; Birsoy, O.; Jairam, S.; Li, Y.; Yang, C.; Somar, J.; Rai, V.; Syed, A.; Benayed, R.; more...
    Journal of Molecular Diagnostics (2019)

    Fulltext@MSK | Save
  • Germline RAD51B loss-of-function variants confer susceptibility to hereditary breast and ovarian cancers and result in homologous recombination deficient tumors
    Meeting Abstract

    Mandelker, D.; Mukherjee, S.; Setton, J.; Cadoo, K.; Selenica, P.; Kemel, Y.; Ceyhan-Birsoy, O.; Sheehan, M.; Tkachuk, K.; Brown, D.; more...
    Journal of Molecular Diagnostics (2019)

    Fulltext@MSK | Save
  • Improved screening for cancer predisposition mutations in patients with advanced solid tumors enabled by tumor-normal sequencing
    Meeting Abstract

    Mandelker, D.; Zhang, L.; Kemel, Y.; Stadler, Z.; Joseph, V.; Zehir, A.; Pradhan, N.; Arnold, A. G.; Walsh, M.; Birsoy, O.; more...
    Journal of Molecular Diagnostics (2017)

    Fulltext@MSK | Save
  • A two-for-one deal: Detecting germline cancer predisposition variants concurrently with tumor somatic mutations in 777 patients analyzed by MSK-IMPACT
    Meeting Abstract

    Mandelker, D.; Li, Y.; Prasad, M.; Syed, A.; Balakrishnan, A. R.; Chandramohan, R.; Delair, D.; Argueta, S.; Yang, C.; Arnold, A.; more...
    Journal of Molecular Diagnostics (2016)

    Fulltext@MSK | Save
  • cDNA analysis demonstrates that the BRCA2 intronic variant IVS4-12del5 is a deleterious mutation
    Journal Article

    Zhang, L.; Bacares, R.; Boyar, S.; Hudis, C.; Nafa, K.; Offit, K.
    Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis (2009)

    Fulltext@MSK | Save
  • Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: A case-control study
    Journal Article

    Narod, S. A.; Brunet, J. S.; Ghadirian, P.; Robson, M.; Heimdal, K.; Neuhausen, S. L.; Stoppa-Lyonnet, D.; Lerman, C.; Pasini, B.; De Los Rios, P.; more...
    Lancet (2000)

    Fulltext@MSK | Save
  • New BRCA2 mutation in an Ashkenazi Jewish family with breast and ovarian cancer
    Journal Article

    Robson, M. E.; Offit, K.
    Lancet (1997)

    Fulltext@MSK | Save